1. Volume 70, Issue 3, Pages 447-455 (September 2016)
Magnetic Resonance Imaging–Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial 
Joseph L. Chin, Michele Billia, James Relle, Matthias C. Roethke, Ionel V. Popeneciu, Timur H. Kuru, Gencay Hatiboglu, Maya B. Mueller-Wolf, Johann Motsch, Cesare Romagnoli, Zahra Kassam, Christopher C. Harle, Jason Hafron, Kiran R. Nandalur, Blaine A. Chronik, Mathieu Burtnyk, Heinz-Peter Schlemmer, Sascha Pahernik 
European Urology 
Volume 70, Issue 3, Pages (September 2016)
DOI: /j.eururo
Copyright © Terms and Conditions

2. Fig. 1
Treatment with magnetic resonance imaging–guided transurethral ultrasound ablation.
ECD=endorectal cooling device; UA=ultrasound applicator.
European Urology  , DOI: ( /j.eururo )
Copyright © Terms and Conditions

3. Fig. 2
(a) Maximum temperature distribution measured during treatment; (b) Visualization of the peripheral region of enhancement surrounding the non-perfused volume on CE-MRI acquired immediately after treatment. Images are oblique-axial transverse to the UA.
CE-MRI=contrast-enhanced magnetic resonance imaging; MRI=magnetic resonance imaging.
European Urology  , DOI: ( /j.eururo )
Copyright © Terms and Conditions

4. Fig. 3 Temporal change in continence and erectile function.
CI=confidence interval; G=grade; IIEF=International Index of Erectile Function.
European Urology  , DOI: ( /j.eururo )
Copyright © Terms and Conditions